Measurement of Persistence and Adherence to Regimens of IOP-Lowering Glaucoma Medications Using Pharmacy Claims Data
Authors:
- Jacob WilenskyJWJacob Wilensky
- Richard G. FiscellaRFRichard G. Fiscella
- Angeline M. CarlsonACAngeline M. Carlson
- Lisa S. MorrisLMLisa S. Morris
- John WaltJWJohn Walt
- 1 January 2006
- journal article
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 141 (1) , 28-33
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Persistency and treatment failure in newly diagnosed open angle glaucoma patients in the United KingdomBritish Journal of Ophthalmology, 2004
- Patient persistency with topical ocular hypotensive therapy in a managed care populationAmerican Journal of Ophthalmology, 2004
- Persistency with latanoprost or timolol in primary open-angle glaucoma suspectsAmerican Journal of Ophthalmology, 2004
- Medication-related predictors of health-related quality of life in glaucoma patients enrolled in a medicare health maintenance organizationThe American Journal of Geriatric Pharmacotherapy, 2003
- Compliance Barriers in Glaucoma: A Systematic ClassificationJournal of Glaucoma, 2003
- Use of pharmacy claims databases to determine rates of medication adherenceAdvances in Therapy, 2003
- Patient Persistency with ocular prostaglandin therapy: A population-based, retrospective studyClinical Therapeutics, 2003
- Causes Of Non-Compliance With Drug Regimens In Glaucoma Patients: A Qualitative StudyJournal of Ocular Pharmacology and Therapeutics, 2002
- Compliance from Self-Reported versus Pharmacy Claims Data with Metered-Dose InhalersAnnals of Pharmacotherapy, 2001
- A Miniature Compliance Monitor for Eyedrop MedicationArchives of Ophthalmology (1950), 1984